Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cunzhen Zhang

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Drug Metabolism Reviews|September 30, 2025
Research on the content and activity of CYP450 enzymes in human liverCunzhen Zhang, Yan Fang, Lin Jia, et al.
Frontiers in Immunology|June 25, 2025
Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinomaZhuoran Wang, Cunzhen Zhang, Jianhua Yin, et al.
Frontiers in Immunology|July 15, 2025
Correction: Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinomaZhuoran Wang, Cunzhen Zhang, Jianhua Yin, et al.
Clinics and Research in Hepatology and Gastroenterology|August 1, 2021
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reportsHaibei Xin, Cunzhen Zhang, Zhiwen Ding, et al.
Biomedicines|January 25, 2025
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic DrugsCunzhen Zhang, Jiyao Wang, Lin Jia, et al.
Frontiers in Oncology|September 25, 2023
Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinomaZhuoran Wang, Nan Li, Peng Cai, et al.
Current Drug Metabolism|May 8, 2026
Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in MiceCunzhen Zhang, Rui Yang, Jun Ma, et al.
Oncotargets and Therapy|July 1, 2015
Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasisMeiling Lu, Jinghua Li, Zaili Luo, et al.
Cancer Letters|May 9, 2013
Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cellsHaiyang Chen, Zaili Luo, Wen Sun, et al.
Computers in Biology and Medicine|June 21, 2024
A novel risk scoring system predicts overall survival of hepatocellular carcinoma using cox proportional hazards machine learning methodHaibei Xin, Yuanfeng Li, Quanlei Wang, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Drug Metabolism Reviews|September 30, 2025
Research on the content and activity of CYP450 enzymes in human liverCunzhen Zhang, Yan Fang, Lin Jia, et al.
Frontiers in Immunology|June 25, 2025
Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinomaZhuoran Wang, Cunzhen Zhang, Jianhua Yin, et al.
Frontiers in Immunology|July 15, 2025
Correction: Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinomaZhuoran Wang, Cunzhen Zhang, Jianhua Yin, et al.
Clinics and Research in Hepatology and Gastroenterology|August 1, 2021
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reportsHaibei Xin, Cunzhen Zhang, Zhiwen Ding, et al.
Biomedicines|January 25, 2025
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic DrugsCunzhen Zhang, Jiyao Wang, Lin Jia, et al.
Frontiers in Oncology|September 25, 2023
Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinomaZhuoran Wang, Nan Li, Peng Cai, et al.
Current Drug Metabolism|May 8, 2026
Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in MiceCunzhen Zhang, Rui Yang, Jun Ma, et al.
Oncotargets and Therapy|July 1, 2015
Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasisMeiling Lu, Jinghua Li, Zaili Luo, et al.
Cancer Letters|May 9, 2013
Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cellsHaiyang Chen, Zaili Luo, Wen Sun, et al.
Computers in Biology and Medicine|June 21, 2024
A novel risk scoring system predicts overall survival of hepatocellular carcinoma using cox proportional hazards machine learning methodHaibei Xin, Yuanfeng Li, Quanlei Wang, et al.
Pageof 3